Table 1.
Summary of scenarios
| Academic Inc | Reformation | In the public eye | Global academic partnership | Fully engaged | |
|---|---|---|---|---|---|
| Description | Academic medicine flourishes in the private sector | All teach, learn, research, and improve | Success comes from delighting patients, the public, and media | Academic medicine for global health equity | Academic medicine engages energetically with all stakeholders |
| Main features | Medical research, training, and service are commercial business activities | Academic medicine disappears | Extreme consumerism | Global cooperative networks devoted to redressing health inequalities and 10:90 gap | Strong connections among patients, policy makers, practitioners, and the public |
| Research and education integrated with health care | Patients govern academic medicine | ||||
| Continual use of media | |||||
| Medical education | Private medical schools | Teamwork | Conducted by expert patients | Centred around improving global health | Medical training is energised and community based |
| Major investment in information technology | Learning by doing | Responsiveness to patients is key value | Partnerships between medical schools in developed and developing countries | Students help drive the agenda | |
| Some niche schools (care of elderly people, rural medicine, etc) | Competency based assessment | ||||
| Research | Privatised, takes place in an array of different companies | Research and quality improvement are simultaneous | Patients determine priorities, through game shows or citizens' juries | Public health and basic science equally valued | Conducted by groups of diversely skilled individuals, including stakeholders |
| Responsive to the needs of customers | Translational research favoured | ||||
| Decision making and governance | Corporate governance | Leadership provided by societies of practitioners and patients | Bottom up: patients in charge | Global governance made up of institutional networks, policy makers, politicians, and the public | Dynamic organisations of all stakeholders to guide academic medicine |
| Disadvantages | Efficiency and effectiveness trump equity | Lacks stability because requires shared values | Advances in science and technology subject to fads and fashion | Idealistic | Academic medicine may be perceived as “dumbed down” |
| Two tier system—brain drain and 10:90 gap preserved | Decision making could be slow | Job insecurity among practitioners | Requires enormous political will and global cooperation | May lose elite status, originality, and independent thinking | |
| Innovation may suffer | Individuals sometimes could not shine | Little regulation of health information |